111 related articles for article (PubMed ID: 8817248)
1. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid.
Jacob S; Henriksen EJ; Tritschler HJ; Augustin HJ; Dietze GJ
Exp Clin Endocrinol Diabetes; 1996; 104(3):284-8. PubMed ID: 8817248
[TBL] [Abstract][Full Text] [Related]
2. Improvement of glucose metabolism in patients with type II diabetes after treatment with a hemodialysate.
Jacob S; Dietze GJ; Machicao F; Kuntz G; Augustin HJ
Arzneimittelforschung; 1996 Mar; 46(3):269-72. PubMed ID: 8901147
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid.
Jacob S; Henriksen EJ; Schiemann AL; Simon I; Clancy DE; Tritschler HJ; Jung WI; Augustin HJ; Dietze GJ
Arzneimittelforschung; 1995 Aug; 45(8):872-4. PubMed ID: 7575750
[TBL] [Abstract][Full Text] [Related]
4. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
Taniguchi A; Fukushima M; Sakai M; Kataoka K; Nagata I; Doi K; Arakawa H; Nagasaka S; Tokuyama K; Nakai Y
Metabolism; 2000 Aug; 49(8):1001-5. PubMed ID: 10954017
[TBL] [Abstract][Full Text] [Related]
5. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
[TBL] [Abstract][Full Text] [Related]
6. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
[TBL] [Abstract][Full Text] [Related]
7. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
[TBL] [Abstract][Full Text] [Related]
8. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
9. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus.
Migdalis IN; Zachariadis D; Kalogeropoulou K; Nounopoulos C; Bouloukos A; Samartzis M
Diabet Med; 1996 May; 13(5):434-40. PubMed ID: 8737025
[TBL] [Abstract][Full Text] [Related]
10. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
11. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H
Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
[TBL] [Abstract][Full Text] [Related]
12. Metabolic impact of a family history of Type 2 diabetes. Results from a European multicentre study (EGIR).
Vaag A; Lehtovirta M; Thye-Rönn P; Groop L;
Diabet Med; 2001 Jul; 18(7):533-40. PubMed ID: 11553181
[TBL] [Abstract][Full Text] [Related]
13. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
Vaag A; Alford F; Beck-Nielsen H
Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
[TBL] [Abstract][Full Text] [Related]
14. Patterns of glucose and lipid abnormalities in black NIDDM subjects.
Chaiken RL; Banerji MA; Pasmantier R; Huey H; Hirsch S; Lebovitz HE
Diabetes Care; 1991 Nov; 14(11):1036-42. PubMed ID: 1797484
[TBL] [Abstract][Full Text] [Related]
15. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen MR
Diabet Med; 1993 Dec; 10(10):950-7. PubMed ID: 8306591
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.
Forsblom CM; Eriksson JG; Ekstrand AV; Teppo AM; Taskinen MR; Groop LC
Diabetologia; 1995 Mar; 38(3):363-9. PubMed ID: 7758885
[TBL] [Abstract][Full Text] [Related]
17. How insulin resistant are patients with noninsulin-dependent diabetes mellitus?
Reaven GM; Chen YD; Donner CC; Fraze E; Hollenbeck CB
J Clin Endocrinol Metab; 1985 Jul; 61(1):32-6. PubMed ID: 3889039
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.
Jacob S; Ruus P; Hermann R; Tritschler HJ; Maerker E; Renn W; Augustin HJ; Dietze GJ; Rett K
Free Radic Biol Med; 1999 Aug; 27(3-4):309-14. PubMed ID: 10468203
[TBL] [Abstract][Full Text] [Related]
19. Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity.
Yamanouchi K; Shinozaki T; Chikada K; Nishikawa T; Ito K; Shimizu S; Ozawa N; Suzuki Y; Maeno H; Kato K
Diabetes Care; 1995 Jun; 18(6):775-8. PubMed ID: 7555502
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.
Ferri C; Carlomagno A; Coassin S; Baldoncini R; Cassone Faldetta MR; Laurenti O; Properzi G; Santucci A; De Mattia G
Diabetes Care; 1995 Feb; 18(2):226-33. PubMed ID: 7729302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
